These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1012 related items for PubMed ID: 19298567

  • 1. The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial.
    Sumner G, Salehian O, Yi Q, Healey J, Mathew J, Al-Merri K, Al-Nemer K, Mann JF, Dagenais G, Lonn E, HOPE Investigators.
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):781-7. PubMed ID: 19298567
    [Abstract] [Full Text] [Related]

  • 2. Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction.
    Teo KK, Mitchell LB, Pogue J, Bosch J, Dagenais G, Yusuf S, HOPE Investigators.
    Circulation; 2004 Sep 14; 110(11):1413-7. PubMed ID: 15353497
    [Abstract] [Full Text] [Related]

  • 3. Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial.
    Dagenais GR, Yi Q, Lonn E, Sleight P, Ostergren J, Yusuf S, HOPE Trial Investigators.
    Eur J Cardiovasc Prev Rehabil; 2005 Feb 14; 12(1):75-81. PubMed ID: 15703510
    [Abstract] [Full Text] [Related]

  • 4. The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.
    Can J Cardiol; 1996 Feb 14; 12(2):127-37. PubMed ID: 8605634
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.
    Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651
    [Abstract] [Full Text] [Related]

  • 8. The HOPE Study (Heart Outcomes Prevention Evaluation).
    Sleight P.
    J Renin Angiotensin Aldosterone Syst; 2000 Mar 20; 1(1):18-20. PubMed ID: 11967789
    [Abstract] [Full Text] [Related]

  • 9. Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial).
    Ho JE, Bittner V, Demicco DA, Breazna A, Deedwania PC, Waters DD.
    Am J Cardiol; 2010 Apr 01; 105(7):905-11. PubMed ID: 20346304
    [Abstract] [Full Text] [Related]

  • 10. Diabetes and the HOPE study: implications for macrovascular and microvascular disease.
    Gerstein HC.
    Int J Clin Pract Suppl; 2001 Jan 01; (117):8-12. PubMed ID: 11715357
    [Abstract] [Full Text] [Related]

  • 11. Comorbidity and myocardial dysfunction are the main explanations for the higher 1-year mortality in acute myocardial infarction with left bundle-branch block.
    Stenestrand U, Tabrizi F, Lindbäck J, Englund A, Rosenqvist M, Wallentin L.
    Circulation; 2004 Oct 05; 110(14):1896-902. PubMed ID: 15451802
    [Abstract] [Full Text] [Related]

  • 12. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators.
    Cleland JG, Erhardt L, Murray G, Hall AS, Ball SG.
    Eur Heart J; 1997 Jan 05; 18(1):41-51. PubMed ID: 9049514
    [Abstract] [Full Text] [Related]

  • 13. Relation of obesity to heart failure hospitalization and cardiovascular events in persons with stable coronary heart disease (from the Heart and Soul Study).
    Spies C, Farzaneh-Far R, Na B, Kanaya A, Schiller NB, Whooley MA.
    Am J Cardiol; 2009 Oct 01; 104(7):883-9. PubMed ID: 19766751
    [Abstract] [Full Text] [Related]

  • 14. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.
    Winkel TA, Hoeks SE, Schouten O, Zeymer U, Limbourg T, Baumgartner I, Bhatt DL, Steg PG, Goto S, Röther J, Cacoub PP, Verhagen HJ, Bax JJ, Poldermans D.
    Eur J Vasc Endovasc Surg; 2010 Jul 01; 40(1):9-16. PubMed ID: 20385507
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin inhibition in renovascular disease: a population-based cohort study.
    Hackam DG, Duong-Hua ML, Mamdani M, Li P, Tobe SW, Spence JD, Garg AX.
    Am Heart J; 2008 Sep 01; 156(3):549-55. PubMed ID: 18760140
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, Hsia J, Gersh BJ, Rifai N, Ridker PM, Pfeffer MA, Braunwald E, PEACE Investigators.
    Circulation; 2007 Mar 27; 115(12):1528-36. PubMed ID: 17372173
    [Abstract] [Full Text] [Related]

  • 17. Usefulness of either or both left and right bundle branch block at baseline or during follow-up for predicting death in patients following acute myocardial infarction.
    Bogale N, Orn S, James M, McCarroll K, de Luna AB, Dickstein K, OPTIMAAL Investigators.
    Am J Cardiol; 2007 Mar 01; 99(5):647-50. PubMed ID: 17317365
    [Abstract] [Full Text] [Related]

  • 18. Relation of bundle branch block to long-term (four-year) mortality in hospitalized patients with systolic heart failure.
    Barsheshet A, Goldenberg I, Garty M, Gottlieb S, Sandach A, Laish-Farkash A, Eldar M, Glikson M.
    Am J Cardiol; 2011 Feb 15; 107(4):540-4. PubMed ID: 21184999
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
    Pietrasik G, Goldenberg I, McNitt S, Polonsky B, Moss AJ, Zareba W.
    J Cardiovasc Electrophysiol; 2009 Apr 15; 20(4):395-400. PubMed ID: 19017351
    [Abstract] [Full Text] [Related]

  • 20. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
    Aguilar D, Solomon SD, Køber L, Rouleau JL, Skali H, McMurray JJ, Francis GS, Henis M, O'Connor CM, Diaz R, Belenkov YN, Varshavsky S, Leimberger JD, Velazquez EJ, Califf RM, Pfeffer MA.
    Circulation; 2004 Sep 21; 110(12):1572-8. PubMed ID: 15364810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.